Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
GCY | Ann: Operational and Corporate Update | 28/03/19 | 21 | 6.3K | |||
|
|||||||
GCY | Ann: Equity Raising Presentation | 28/03/19 | 4 | 1.4K | |||
|
|||||||
GCY | Ann: Trading Suspension | 27/03/19 | 84 | 95K | |||
|
|||||||
GCY | News: GCY Gascoyne Resources Posts HY Loss Attributable Of $47.2 Million | 27/03/19 | 0 | 176 | |||
|
|||||||
GCY | News: GCY Gascoyne Resources Gives HY Production Guidance Of 29,000 Oz - 34,000 Oz | 27/03/19 | 0 | 162 | |||
|
|||||||
GCY | Ann: Half Year Accounts | 27/03/19 | 0 | 238 | |||
|
|||||||
GCY | Ann: Suspension from Official Quotation | 19/03/19 | 38 | 142K | |||
|
|||||||
GCY | Finally some clarity and credibility | 15/03/19 | 24 | 19K | |||
|
See All Discussions